Clinical trial
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian…
NCT00003998 · University of Glasgow, Other · Completed
Key facts
| NCT number | NCT00003998 |
|---|---|
| Title | Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer |
| Official title | A Randomized, Prospective Phase III Comparison of Paclitaxel-Carboplatin Versus Docetaxel-Carboplatin as First Line Chemotherapy in Stage Ic-IV Epithelial Ovarian Cancer |
| Lead sponsor | University of Glasgow, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, docetaxel, paclitaxel, surgical procedure |
| Enrollment | 1,050 |
| Start date | Oct 1, 1998 |
| Completion | Dec 1, 2004 |
| First posted | Jun 3, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: